CEO Daily
Presented By
Page 32 of 100
Get today’s market-moving stories from the CEO perspective. Each weekday, Fortune's Diane Brady and our world-class newsroom offer perspective, as well as insights from fellow CEOs and industry leaders, on the top stories shaping the world of business. Start your mornings informed by the sharpest minds in business—sign up here.

NewslettersThree-quarters of employees say work stress is causing weight gain. Headspace CEO blames ‘political discourse’
By Diane Brady and Nicholas GordonJune 14, 2024

NewslettersAon unveils first-its-kind insurance program in Ukraine to help jumpstart rebuilding of the private sector
By Diane Brady and Nicholas GordonJune 13, 2024

NewslettersElon Musk and Larry Fink—ideological opposites—find common ground: the pursuit of shareholder democracy
By Peter Vanham and Nicholas GordonJune 12, 2024

By Diane Brady and Nicholas GordonJune 11, 2024

By Paolo Confino and Claire ZillmanJune 10, 2024

NewslettersTesla shareholders will soon get to decide whether Elon Musk deserves his record-breaking $46 billion pay package
By Clay Chandler and Nicholas GordonJune 7, 2024

NewslettersFortune 500 CEOs can’t stop thinking about AI—even if they have modest ambitions for the new tech
By Matthew Heimer and Nicholas GordonJune 6, 2024

By Peter Vanham and Nicholas GordonJune 5, 2024

NewslettersProfits are up, AI is ascendant, and California is back on top in the 70th edition of the Fortune 500
By Alyson Shontell and Nicholas GordonJune 4, 2024

NewslettersThe U.S. drugstore is caught in a perfect storm, ditched by customers and squeezed by insurance middlemen: ‘Pharmacies are in shambles’
By Maria Aspan and Nicholas GordonJune 3, 2024

NewslettersShein’s long-awaited IPO could be one of the biggest in years—if it can just figure out where U.S. and Chinese regulators will let it debut
By Clay Chandler and Nicholas GordonMay 31, 2024

By Geoff Colvin and Nicholas GordonMay 30, 2024

NewslettersSanofi’s CEO is giving OpenAI access to its data in the hope of developing drugs more quickly
By Peter Vanham and Nicholas GordonMay 29, 2024

By Phil Wahba and Nicholas GordonMay 28, 2024
Most Popular



